Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market
Intelligent Bio Solutions submitted a 510(k) notification to the FDA for its fingerprint drug screening system to enter the US market.
A company called Intelligent Bio asked the US government to approve its new drug-screening tool that uses fingerprints. This is an important step forward, but approval isn't certain yet—so watch to see if the government says yes or asks for more information.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.